Literature DB >> 17053789

POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination.

Hua He1, Asha S Multani, Wilfredo Cosme-Blanco, Hidetoshi Tahara, Jin Ma, Sen Pathak, Yibin Deng, Sandy Chang.   

Abstract

POT1 (protection of telomere 1) is a highly conserved single-stranded telomeric binding protein that is essential for telomere end protection. Here, we report the cloning and characterization of a second member of the mouse POT family. POT1b binds telomeric DNA via conserved DNA binding oligonucleotide/oligosaccharide (OB) folds. Compared to POT1a, POT1b OB-folds possess less sequence specificity for telomeres. In contrast to POT1a, truncated POT1b possessing only the OB-folds can efficiently localize to telomeres in vivo. Overexpression of a mutant Pot1b allele that cannot bind telomeric DNA initiated a DNA damage response at telomeres that led to p53-dependent senescence. Furthermore, a reduction of the 3' G-rich overhang, increased chromosomal fusions and elevated homologous recombination (HR) were observed at telomeres. shRNA mediated depletion of endogenous Pot1b in Pot1a deficient cells resulted in increased chromosomal aberrations. Our results indicate that POT1b plays important protective functions at telomeres and that proper maintenance of chromosomal stability requires both POT proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053789      PMCID: PMC1630418          DOI: 10.1038/sj.emboj.7601294

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins.

Authors:  Dan Liu; Matthew S O'Connor; Jun Qin; Zhou Songyang
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

2.  p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2.

Authors:  J Karlseder; D Broccoli; Y Dai; S Hardy; T de Lange
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

3.  TRF2 protects human telomeres from end-to-end fusions.

Authors:  B van Steensel; A Smogorzewska; T de Lange
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

4.  POT1 and TRF2 cooperate to maintain telomeric integrity.

Authors:  Qin Yang; Yun-Ling Zheng; Curtis C Harris
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

5.  G-strand overhangs on telomeres in telomerase-deficient mouse cells.

Authors:  M T Hemann; C W Greider
Journal:  Nucleic Acids Res       Date:  1999-10-15       Impact factor: 16.971

6.  Mammalian telomeres end in a large duplex loop.

Authors:  J D Griffith; L Comeau; S Rosenfield; R M Stansel; A Bianchi; H Moss; T de Lange
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

7.  Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.

Authors:  Colleen Kelleher; Isabel Kurth; Joachim Lingner
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

8.  Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.

Authors:  Ming Lei; Elaine R Podell; Thomas R Cech
Journal:  Nat Struct Mol Biol       Date:  2004-11-21       Impact factor: 15.369

9.  TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres.

Authors:  Jeffrey Zheng-Sheng Ye; Jill R Donigian; Megan van Overbeek; Diego Loayza; Yan Luo; Andrew N Krutchinsky; Brian T Chait; Titia de Lange
Journal:  J Biol Chem       Date:  2004-08-16       Impact factor: 5.157

10.  Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint.

Authors:  B Garvik; M Carson; L Hartwell
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  60 in total

1.  Expression of human protection of telomere 1 correlates with telomere length and radiosensitivity in the human laryngeal cancer Hep-2 cell line.

Authors:  Han Lei; Dali Feng; Fuxiang Zhou; Hui Xu; Tian Tang; Haijun Yu; Conghua Xie; Yunfeng Zhou
Journal:  Oncol Lett       Date:  2015-06-05       Impact factor: 2.967

2.  Of wombats and whales: telomere tales in Madrid. Conference on telomeres and telomerase.

Authors:  Jan Karlseder; Julia Promisel Cooper
Journal:  EMBO Rep       Date:  2007-05-18       Impact factor: 8.807

Review 3.  DNA damage response at functional and dysfunctional telomeres.

Authors:  Maria Pia Longhese
Journal:  Genes Dev       Date:  2008-01-15       Impact factor: 11.361

Review 4.  Telomere dysfunction and tumour suppression: the senescence connection.

Authors:  Yibin Deng; Suzanne S Chan; Sandy Chang
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

5.  Distinct roles of TRF1 in the regulation of telomere structure and lengthening.

Authors:  Keiji Okamoto; Tomohiko Iwano; Makoto Tachibana; Yoichi Shinkai
Journal:  J Biol Chem       Date:  2008-06-28       Impact factor: 5.157

Review 6.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.

Authors:  Paula Martínez; María A Blasco
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

7.  p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.

Authors:  Yang Wang; Norman Sharpless; Sandy Chang
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

8.  Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN.

Authors:  Nausica Arnoult; Carole Saintome; Isabelle Ourliac-Garnier; Jean-François Riou; Arturo Londoño-Vallejo
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

9.  Single strand DNA binding proteins 1 and 2 protect newly replicated telomeres.

Authors:  Peili Gu; Wei Deng; Ming Lei; Sandy Chang
Journal:  Cell Res       Date:  2013-03-05       Impact factor: 25.617

10.  A role for monoubiquitinated FANCD2 at telomeres in ALT cells.

Authors:  Qiang Fan; Fan Zhang; Briana Barrett; Keqin Ren; Paul R Andreassen
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.